[18F]AlF-NOTA-PCP2
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for [18F]AlF-NOTA-PCP2, covering 2025-03-30 to 2025-03-30. Get the full timeline:
Most recent: Clinical Trial Update: Evaluation of [18F]AlF-NOTA-PCP2 PET/CT for PD-L1 Detection in Malignant Tumors [Phase 1, Phase 2]